Skip to main content
Premium Trial:

Request an Annual Quote

ATCC Inks Sales Pact with Life Technologies for GFP Technology

NEW YORK (GenomeWeb News) – ATCC today announced a deal with Life Technologies to sell green fluorescent proteins to distributors, non-commercial customers, and government customers in the research field.

Under the terms of the deal, which excludes the food and environmental safety testing sectors, ATCC will be able to use GFP technology to develop biological materials for the covered research fields.

Life Tech serves as the exclusive for-profit entity to ATCC for GFP-based materials, though the non-profit biological materials resource and standards organization can also obtain GFP materials from third party, non-profit, or government researchers, it said.

ATCC must distribute licensed products with a Limited Label License Agreement accompanying the distribution. Licensed products may be sold to for-profit customers only if they have a license with Life Technologies or GE Healthcare, and ATCC does not have any sublicensing rights.

ATCC will develop and manufacture products at its Manassas, Va., and Gaithersburg, Md., facilities.

"With this license, ATCC can accept a wide variety of GFP-based materials into our collections and we can make these materials available to meet the evolving needs of researchers," Brian A. Pollok, president of ATCC, said in a statement. "ATCC also plans to use GFP technology, together with our unique bioassets, to generate novel products intended to advance understanding in cell biology, infectious disease, and other key research fields."

Financial and other terms were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.